These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31218148)

  • 21. Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis.
    Sell J; Haas NL; Korley FK; Cranford JA; Bassin BS
    West J Emerg Med; 2023 Nov; 24(6):1049-1055. PubMed ID: 38165186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection.
    Chauhan S; Diaz V; Ogbu IR; Sanchez JRP; Manov AE; Shah P
    Cureus; 2024 Aug; 16(8):e66408. PubMed ID: 39246944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed euDKA Associated With Dapagliflozin After Pancreatitis.
    Wu G; Wu S; Tang J; Wu H
    Clin Ther; 2023 Jul; 45(7):e167-e170. PubMed ID: 37248092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis.
    Dutta S; Kumar T; Singh S; Ambwani S; Charan J; Varthya SB
    J Family Med Prim Care; 2022 Mar; 11(3):927-940. PubMed ID: 35495849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report.
    Brown F; McColl T
    J Emerg Med; 2018 Jan; 54(1):109-111. PubMed ID: 29157798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe euglycemic diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor: case report and literature review.
    El Ess MS; ElRishi MA
    Ann Med Surg (Lond); 2023 May; 85(5):2097-2101. PubMed ID: 37228937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
    Chauhan S; Manov A; Dhillon GS; Shah P
    Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
    Dorcely B; Nitis J; Schwartzbard A; Newman JD; Goldberg IJ; Sum M
    Curr Diabetes Rev; 2021; 17(2):243-246. PubMed ID: 32178617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Euglycemic Diabetic Ketoacidosis Caused by Alcoholic Pancreatitis and Starvation Ketosis.
    Han HJ; Cole AE; Verma A
    J Gen Intern Med; 2023 Apr; 38(5):1299-1301. PubMed ID: 36689144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Presenting with Acute Pancreatitis.
    Badwal K; Tariq T; Peirce D
    Case Rep Endocrinol; 2018; 2018():6450563. PubMed ID: 30159178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports.
    Khedr A; Hennawi HA; Khan MK; Eissa A; Mir M; Rauf I; Nitesh J; Surani S; Khan SA
    World J Clin Cases; 2023 Aug; 11(24):5700-5709. PubMed ID: 37727728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertriglyceridemia-Induced Acute Pancreatitis, Euglycemic Diabetic Ketoacidosis and COVID-19 Infection in a Patient With Type 2 Diabetes Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Acevedo-Mendez BA; Ye Y; Hajizadeh N; Myers A
    Cureus; 2021 Nov; 13(11):e19828. PubMed ID: 34853772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath SD; Kumar U; Shrivastava V
    Cureus; 2024 Apr; 16(4):e58341. PubMed ID: 38756291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Euglycemic Diabetic Ketoacidosis: A Review.
    Modi A; Agrawal A; Morgan F
    Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
    Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
    Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
    Nappi F; La Verde A; Carfora G; Garofalo C; Provenzano M; Sasso FC; De Nicola L
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31405158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.
    Fieger EI; Fadel KM; Modarres AH; Wickham EP; Wolver SE
    AACE Clin Case Rep; 2020; 6(6):e330-e333. PubMed ID: 33244496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
    Wang KM; Isom RT
    Kidney Med; 2020; 2(2):218-221. PubMed ID: 32734242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Euglycemic Ketoacidosis in a Patient without Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure.
    Miyazaki M; Nakano M; Takahashi H; Isaka Y; Hiura Y
    Am J Case Rep; 2024 Jul; 25():e943945. PubMed ID: 38985686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.